慢性甲状旁腺功能减退症患者的骨骼健康状况:加拿大国家甲状旁腺功能减退症登记研究(CNHR)结果
该前瞻性研究纳入加拿大国家甲状旁腺功能减退症登记研究中101例慢性甲状旁腺功能减退症成人患者,评估基线骨折、骨密度、骨小梁评分及骨生物标志物。绝经后女性中35%经骨密度或脆性骨折诊断骨质疏松,4%两者兼有;50岁及以上男性中3例(33.3%;n=3/9)经骨密度或脆性骨折诊断骨质疏松。研究提示对绝经后女性和50岁及以上男性慢性甲状旁腺功能减退症患者需密切随访骨骼健康。
要点
- 绝经后女性中35%经骨密度或脆性骨折诊断骨质疏松,4%两者兼有。
- 50岁及以上男性中3例(33.3%;n=3/9)经骨密度或脆性骨折诊断骨质疏松。
- 绝经前女性未报告脆性骨折或低骨密度。
核心结论
- 绝经后女性中35%经骨密度或既往脆性骨折诊断骨质疏松,4%两者兼有。
- 50岁及以上男性中3例(33.3%;n=3/9)经骨密度或脆性骨折诊断骨质疏松。
- 作者认为对绝经后女性和50岁及以上男性慢性甲状旁腺功能减退症患者需密切随访骨骼健康。
研究设计与样本
- 前瞻性研究,纳入加拿大国家甲状旁腺功能减退症登记研究中的慢性甲状旁腺功能减退症成人患者。
- 分析101例患者:男性18例、绝经前女性35例、绝经后女性48例。
- 基线评估临床特征、骨折、生化指标、血清骨生物标志物、脆性骨折、腰椎、股骨颈、全髋、桡骨1/3部位骨密度及骨小梁评分。
主要发现
- 甲状旁腺功能减退症平均(SD)发病年龄40.7(16.8)岁,平均病程11.2(8.6)年。
- 最常见病因为手术后(74.3% vs 非手术25.7%)。
- 基线时多数患者接受钙剂(89%)和活性维生素D(80%)治疗。
- 绝经前女性未报告脆性骨折或低骨密度。
- 绝经后女性腰椎、股骨颈、全髋骨密度及骨小梁评分显著低于绝经前女性。
关键数值与推荐
- 绝经后女性骨质疏松(经骨密度或脆性骨折)患病率35%,两者兼有者4%。
- 50岁及以上男性骨质疏松(经骨密度或脆性骨折)3例(33.3%;n=3/9)。
临床怎么用
- 作者认为对绝经后女性慢性甲状旁腺功能减退症患者需密切随访骨骼健康。
- 作者认为对50岁及以上男性慢性甲状旁腺功能减退症患者需密切随访骨骼健康。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: In the CNHR study, 35% of postmenopausal women had osteoporosis by BMD or fragility fracture, and 4% had both. Three men ≥ 50 had osteoporosis by BMD or fragility fracture (33.3%; n = 3/9). This suggests that close follow-up of skeletal health is necessary in postmenopausal women, and men ≥ 50 with chronic HypoPT. PURPOSE: Chronic hypoparathyroidism (HypoPT) has been associated with decreased bone turnover and abnormalities in bone mineral density (BMD), microarchitecture, and strength. Current guidelines do not recommend systematic evaluation of skeletal health in patients with chronic HypoPT. Our study assessed skeletal health in pre- and postmenopausal women with chronic HypoPT and adult men. METHODS: This prospective study enrolled adults with chronic HypoPT from the Canadian National Hypoparathyroidism Registry. Clinical characteristics, bone fractures, biochemistry, and serum bone biomarkers were assessed at baseline. Skeletal health evaluation included assessments of fragility fractures, BMD at lumbar spine (LS), femoral neck (FN), total hip (TH), 1/3 radial sites, trabecular bone score (TBS), and bone biomarkers. RESULTS: We present the baseline data of the patients enrolled in the registry. We analyzed a total of 101 patients: 18 men, 35 premenopausal, and 48 postmenopausal women. The mean (SD) age at the onset of HypoPT was 40.7 (16.8) years, and the average disease duration was 11.2 (8.6) years. The most common etiology was postsurgical (74.3% vs. 25.7% non-surgical). Most patients received calcium supplements (89%) and active vitamin D (80%) at baseline. No fragility fractures or low BMD were reported in premenopausal women. However, BMD at LS, FN, TH, and TBS were significantly lower in postmenopausal compared to premenopausal women. CONCLUSIONS: Overall, 35% of postmenopausal women had osteoporosis by BMD or prior fragility fracture, and 4% had both. Three men ≥ 50 years had osteoporosis by BMD or fragility fracture (33.3%; n = 3/9). This study suggests that close follow-up of skeletal health is necessary in postmenopausal women with chronic HypoPT and men ≥ 50 years.
引用
- Khan AA, AbuAlrob H, Ali DS, et al. Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR). Osteoporos Int. 2025. PMID: 39955688. doi:10.1007/s00198-025-07410-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。